Cyclin A in cell cycle control and cancer

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Cellular and Molecular Life Sciences (CMLS)

• Publication date

  2002-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00018-002-8510-yPMID 12363035PMCID PMC11337442
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Low frequency of allelic loss in the cyclin A gene in human hepatocellular carcinomas: a study based on PCR.

  2008cited by this paper
• Aberrant expression of cyclin A and cyclin B1 proteins in oral carcinoma.

  2007cited by this paper
• Activation of cyclin-dependent kinases CDC2 and CDK2 in hepatocellular carcinoma.

  2002cited by this paper
• Correlation between the expression of cyclin A protein and p53 activity in oral squamous cell carcinomas.

  2001cited by this paper
• Over‐expression of cyclin a is highly associated with early relapse and reduced survival in patients with primary breast carcinomas

  2001cited by this paper
• Cyclin a Is Destroyed in Prometaphase and Can Delay Chromosome Alignment and Anaphase

  2001cited by this paper
• Expression of cell cycle proteins in ovarian carcinoma cells in serous effusions-biological and prognostic implications.

  2001cited by this paper
• Altered myelopoiesis and the development of acute myeloid leukemia in transgenic mice overexpressing cyclin A1

  2001cited by this paper
• Cyclin A-CDK Phosphorylation Regulates MDM2 Protein Interactions*

  2001cited by this paper
• Cyclin A and Ki-67 with DNA content in benign and malignant prostatic epithelial lesions.

  2001cited by this paper
• Telomerase activity, Ki-67, cyclin D1 and A expression, and apoptosis in solitary fibrous tumors: additional features of a predictable course?

  2001cited by this paper
• APC/C‐mediated destruction of the centrosomal kinase Nek2A occurs in early mitosis and depends upon a cyclin A‐type D‐box

  2001cited by this paper
• Anaphase-Promoting Complex/Cyclosome–Dependent Proteolysis of Human Cyclin a Starts at the Beginning of Mitosis and Is Not Subject to the Spindle Assembly Checkpoint

  2001cited by this paper
• Cyclin A expression in superficial spreading malignant melanomas correlates with clinical outcome

  2001cited by this paper
• Cyclin E is the only cyclin-dependent kinase 2-associated cyclin that predicts metastasis and survival in early stage non-small cell lung cancer.

  2001cited by this paper
• DNA damage leads to a Cyclin A-dependent delay in metaphase-anaphase transition in the Drosophila gastrula.

  2001cited by this paper
• The schedule of destruction of three mitotic cyclins can dictate the timing of events during exit from mitosis.

  2001cited by this paper
• Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver

  2001cited by this paper
• Mitotic degradation of cyclin A is mediated by multiple and novel destruction signals.

  2001cited by this paper
• Enhanced expression of cyclin E and cyclin A in human hepatocellular carcinomas.

  2001cited by this paper
• Mitotic regulation of the APC activator proteins CDC20 and CDH1.

  2000cited by this paper
• On the concentrations of cyclins and cyclin-dependent kinases in extracts of cultured human cells.

  2000cited by this paper
• Human p55(CDC)/Cdc20 associates with cyclin A and is phosphorylated by the cyclin A-Cdk2 complex.

  2000cited by this paper
• A detailed analysis of cyclin A accumulation at the G(1)/S border in normal and transformed cells.

  2000cited by this paper
• Relevance of proliferative and pro-apoptotic factors in non-small-cell lung cancer for patient survival

  2000cited by this paper
• Degradation of Cyclin A Does Not Require Its Phosphorylation by CDC2 and Cyclin-dependent Kinase 2*

  2000cited by this paper
• Detection of telomerase activity and correlation with mitotic and apoptotic indices, Ki‐67 and expression of cyclins D1 and A in cutaneous melanoma

  2000cited by this paper
• Involvement of cyclins in cell proliferation and their clinical implications in soft tissue smooth muscle tumors.

  2000cited by this paper
• Cyclin A activates the DNA polymerase delta -dependent elongation machinery in vitro: A parvovirus DNA replication model.

  2000cited by this paper
• HuR regulates cyclin A and cyclin B1 mRNA stability during cell proliferation

  2000cited by this paper
• Evaluation of Cyclin Expression in Testicular Germ Cell Tumors: Cyclin E Correlates with Tumor Type, Advanced Clinical Stage, and Pulmonary Metastasis

  2000cited by this paper
• Comparison of BrdU and cyclin A as markers of the S-phase in oral precancerous lesions.

  2000cited by this paper
• Overexpression of cyclin A and cyclin B1 proteins in astrocytomas.

  2000cited by this paper
• Prognostic significance of cell cycle proteins and genomic instability in borderline, early and advanced stage ovarian carcinomas

  2000cited by this paper
• Expression and Prognostic Role of Cyclin-Dependent Kinase 1 (cdc2) in Hepatocellular Carcinoma

  2000cited by this paper
• Inhibition of Mcm4,6,7 Helicase Activity by Phosphorylation with Cyclin A/Cdk2*

  2000cited by this paper
• Chromatin-bound Cdc6 persists in S and G2 phases in human cells, while soluble Cdc6 is destroyed in a cyclin A-cdk2 dependent process.

  2000cited by this paper
• Methylation of the Cyclin A1 Promoter Correlates with Gene Silencing in Somatic Cell Lines, while Tissue-Specific Expression of Cyclin A1 Is Methylation Independent

  2000cited by this paper
• CHF: a novel factor binding to cyclin A CHR corepressor element

  1999cited by this paper
• Expression of cyclins A and D and p21(waf1/cip1) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival

  1999cited by this paper
• Delayed early embryonic lethality following disruption of the murine cyclin A2 gene

  1999cited by this paper
• Human Cyclin a Is Required for Mitosis until Mid Prophase

  1999cited by this paper
• Cell cycle-regulated proteolysis of mitotic target proteins.

  1999cited by this paper
• Expression of cyclin A in soft tissue sarcomas correlates with tumor aggressiveness.

  1999cited by this paper
• Cyclin A1 expression in leukemia and normal hematopoietic cells.

  1999cited by this paper
• A high proliferation rate measured by cyclin A predicts a favourable chemotherapy response in soft tissue sarcoma patients

  1999cited by this paper
• CDK1 and cyclin A expression is linked to cell proliferation and associated with prognosis in non-Hodgkin's lymphomas.

  1999cited by this paper
• Expression of cyclin A and D proteins in prostate cancer and their relation to clinopathological variables and patient survival.

  1999cited by this paper
• c-myb transactivates the human cyclin A1 promoter and induces cyclin A1 gene expression.

  1999cited by this paper
• p53 and cyclin a protein expression in squamous carcinoma of the oesophagus

  1999cited by this paper
• Expression of cell cycle regulators in human cutaneous malignant melanoma.

  1999cited by this paper
• Functions of Cyclin A1 in the Cell Cycle and Its Interactions with Transcription Factor E2F-1 and the Rb Family of Proteins

  1999cited by this paper
• Expression of cell cycle markers in colorectal carcinoma: Superiority of cyclin A as an indicator of poor prognosis

  1999cited by this paper
• Expression of cyclins and cyclin‐dependent kinases in smooth muscle tumors of the uterus

  1999cited by this paper
• Cloning of the cyclin A1 Genomic Structure and Characterization of the Promoter Region

  1999cited by this paper
• Phosphorylation of mammalian CDC6 by Cyclin A/CDK2 regulates its subcellular localization

  1999cited by this paper
• Phosphorylation of the cyclosome is required for its stimulation by Fizzy/cdc20.

  1999cited by this paper
• Expression of cell cycle markers in colorectal carcinoma : superiority of cyclin A as an indicator of poor prognosis

  1999cited by this paper
• Accumulation of cyclin B1 requires E2F and cyclin-A-dependent rearrangement of the anaphase-promoting complex

  1999cited by this paper
• Cyclin A1 is predominantly expressed in hematological malignancies with myeloid differentiation

  1998cited by this paper
• Cyclin A1 is required for meiosis in the male mouse

  1998cited by this paper
• Immunohistochemical analysis of cyclin A in astrocytic tumours

  1998cited by this paper
• A new model of cell cycle-regulated transcription: repression of the cyclin A promoter by CDF-1 and anti-repression by E2F

  1998cited by this paper
• Prognostic factors in gastric cancer.

  1998cited by this paper
• Fizzy is required for activation of the APC/cyclosome in Xenopus egg extracts

  1998cited by this paper
• PKA and MPF-activated polo-like kinase regulate anaphase-promoting complex activity and mitosis progression.

  1998cited by this paper
• Prognostic value of ERBB-1, VEGF, cyclin A, FOS, JUN and MYC in patients with squamous cell lung carcinomas.

  1998cited by this paper
• Mitotic cyclins and cyclin-dependent kinases in melanocytic lesions.

  1998cited by this paper
• Substrate recruitment to cyclin-dependent kinase 2 by a multipurpose docking site on cyclin A.

  1998cited by this paper
• Prognostic significance of cyclin expression in human osteosarcoma.

  1998cited by this paper
• Active cyclin A-CDK2 complex, a possible critical factor for cell proliferation in human primary lung carcinomas.

  1998cited by this paper
• Overexpression of cyclin A but not Skp 2 correlates with the tumor relapse of human hepatocellular carcinoma.

  1998cited by this paper
• Immunohistochemical detection of sex steroid receptors, cyclins, and cyclin‐dependent kinases in the normal and neoplastic squamous epithelia of the uterine cervix

  1998cited by this paper
• The regulation of Cdc20 proteolysis reveals a role for APC components Cdc23 and Cdc27 during S phase and early mitosis.

  1998cited by this paper
• Cyclin A and MIB1 (Ki67) as markers of proliferative activity in primary renal neoplasms.

  1998cited by this paper
• Cyclin A overexpression in carcinoma of the renal pelvis and ureter including dysplasia: immunohistochemical findings in relation to prognosis.

  1997cited by this paper
• Dual phosphorylation of the T‐loop in cdk7: its role in controlling cyclin H binding and CAK activity

  1997cited by this paper
• Deregulated expression of E2F-1 induces cyclin A- and E-associated kinase activities independently from cell cycle position

  1997cited by this paper
• Immunohistochemical Detection of Cyclin A with Reference to p53 Expression in Endometrial Endometrioid Carcinomas

  1997cited by this paper
• p27KIP1 blocks cyclin E-dependent transactivation of cyclin A gene expression

  1997cited by this paper
• The cyclin box fold: protein recognition in cell-cycle and transcription control.

  1997cited by this paper
• The MDM2 C-terminal Region Binds to TAFII250 and Is Required for MDM2 Regulation of the Cyclin A Promoter*

  1997cited by this paper
• Phosphorylation of DNA polymerase α-primase by Cyclin A-dependent kinases regulates initiation of DNA replication in vitro

  1997cited by this paper
• Cyclin A is associated with an unfavourable outcome in patients with non-small-cell lung carcinomas.

  1997cited by this paper
• Characterization of a second human cyclin A that is highly expressed in testis and in several leukemic cell lines.

  1997cited by this paper
• Cyclin A message stability varies with the cell cycle.

  1997cited by this paper
• Cyclin/Cdk-dependent initiation of DNA replication in a human cell-free system.

  1997cited by this paper
• Down-regulation of the Cyclin A Promoter by Transforming Growth Factor-β1 Is Associated with a Reduction in Phosphorylated Activating Transcription Factor-1 and Cyclic AMP-responsive Element-binding Protein*

  1997cited by this paper
• Delayed early embryonic lethality following disruption of the murine cyclin A2 gene

  1997cited by this paper
• Dominant-negative cyclin-selective ubiquitin carrier protein E2-C/UbcH10 blocks cells in metaphase.

  1997cited by this paper
• TAFII250-dependent transcription of cyclin A is directed by ATF activator proteins.

  1997cited by this paper
• Anchorage-dependent transcription of the cyclin A gene

  1996cited by this paper
• ATF/CREB site mediated transcriptional activation and p53 dependent repression of the cyclin A promoter

  1996cited by this paper
• Adenovirus E1A activates cyclin A gene transcription in the absence of growth factors through interaction with p107

  1996cited by this paper
• Activation of cyclin E/CDK2 is coupled to site‐specific autophosphorylation and ubiquitin‐dependent degradation of cyclin E.

  1996cited by this paper
• A distinct cyclin A is expressed in germ cells in the mouse.

  1996cited by this paper
• Mutagenic analysis of the destruction signal of mitotic cyclins and structural characterization of ubiquitinated intermediates.

  1996cited by this paper
• Cyclin A expression is under negative transcriptional control during the cell cycle

  1996cited by this paper
• Role for Cyclin A-dependent Kinase in DNA Replication in Human S Phase Cell Extracts*

  1996cited by this paper
• The ‘destruction box’ of cyclin A allows B‐type cyclins to be ubiquitinated, but not efficiently destroyed.

  1996cited by this paper

• Etiology of polyploid giant cancer cells: a new frontier in cancer biology

  2026cites this paper
• Synthesis and Evaluation of 125I-IMPY: Application in Neuroblastoma Tracing and Treatment

  2025cites this paper
• Abemaciclib induces G1 arrest and lysosomal dysfunction in canine melanoma cells: synergistic effects with fenbendazole

  2025cites this paper
• As2S2 Mediates the ROS/P38 MAPK Signaling Pathway to Induce Apoptosis and S-Phase Arrest in Myelodysplastic Syndrome Cells

  2025cites this paper
• Plasticity of mitotic cyclins in promoting the G2–M transition

  2025cites this paper
• Photodynamic Anticancer Efficacy of meso‐tris‐p‐Carboxyphenylporphyrin‐Fullerene Dyads: Apoptosis Induction and Mitochondrial Deregulation in Glioblastoma Therapy

  2025cites this paper
• DNA‐Engineered Modular Nanovaccines Featuring Precise Topology for Enhanced Immunogenicity

  2025cites this paper
• Identification of MAD2L1 as a novel biomarker for hepatoblastoma through bioinformatics and machine learning approaches

  2025cites this paper
• Fulcrum Occupancy-Leverage Perturbation Strategy Enables Rapid Discovery of Potent CDK2-Cyclin A2 Interaction Inhibitors.

  2025cites this paper
• Anticancer Efficacy of Decursin: A Comprehensive Review with Mechanistic Insights

  2025cites this paper
• The tumor microenvironment enhances the expression of cssDNA by modulating cell cycle signaling pathways via SKP2

  2025cites this paper
• Cyclin-dependent protein kinases and cell cycle regulation in biology and disease

  2025cites this paper
• Investigation of galangin against colorectal cancer through MAPK signaling pathway modulation.

  2025cites this paper
• The CDK Inhibitor Dinaciclib Improves Cisplatin Response in Nonseminomatous Testicular Cancer: A Preclinical Study

  2024cites this paper
• Genetic Diversity and Genome-Wide Association Study of Total Phenolics, Flavonoids, and Antioxidant Properties in Potatoes (Solanum tuberosum L.)

  2024cites this paper
• Cyclin A2 Expression as Predictive Biomarker in Muscle-Invasive Upper Tract Urothelial Carcinoma

  2024cites this paper
• Molecular mechanisms of extracellular-ATP-mediated colorectal cancer progression: Implication of purinergic receptors-mediated nucleocytoplasmic shuttling of HuR

  2024cites this paper
• Multiple functions of the nonstructural protein 3D in picornavirus infection

  2024cites this paper
• Uterine cyclin A2–deficient mice as a model of female early pregnancy loss

  2024cites this paper
• NCAPD2 serves as a potential prognostic biomarker for lung adenocarcinoma and promotes cell proliferation, migration, invasion and cell cycle in vitro

  2024cites this paper
• Transcriptomics analysis identified ezrin as a potential druggable target in cervical and gastric cancer cells

  2024cites this paper
• Suppressing SENP1 inhibits esophageal squamous carcinoma cell growth via SIRT6 SUMOylation

  2024cites this paper
• Biomarkers for prognosis of meningioma patients: A systematic review and meta-analysis

  2024cites this paper
• Nano‐Titanium Oxide‐Coated Carbon Nanotubes for Photothermal Therapy in the Treatment of Colorectal Cancer

  2024cites this paper
• Notch signaling mediated repressive effects of resveratrol in inducing caspasedependent apoptosis in MCF-7 breast cancer cells.

  2024cites this paper
• A black phosphorus nanosheet-based RNA delivery system for prostate cancer therapy by increasing the expression level of tumor suppressor gene PTEN via CeRNA mechanism

  2024cites this paper
• Naringin Induces ROS‐Stimulated G1 Cell‐Cycle Arrest and Apoptosis in Nasopharyngeal Carcinoma Cells

  2024cites this paper
• Activation of the FOXM1/ASF1B/PRDX3 axis confers hyperproliferative and antioxidative stress reactivity to gastric cancer.

  2024cites this paper
• Imbalance of redox homeostasis and altered cellular signaling induced by the metal complexes of terpyridine

  2024cites this paper
• Synthesis of eugenol esters derivatives as breast cancer drugs

  2024cites this paper
• Hsa_circ_0005320 affects cell proliferation and the cell cycle via the IGF2BP3/CDK2 axis in bladder cancer.

  2024cites this paper
• Ethynylestradiol feminizes gene expression partly in testis developing as ovotestis and disrupts asymmetric müllerian duct development by eliminating asymmetric gene expression in japanese quail embryos.

  2024cites this paper
• 3-Amide-β-carbolines block the cell cycle by targeting CDK2 and DNA in tumor cells potentially as anti-mitotic agents.

  2024cites this paper
• A novel HDAC6 inhibitor interferes microtubule dynamics and spindle assembly checkpoint and sensitizes cisplatin‐induced apoptosis in castration‐resistant prostate cancer

  2024cites this paper
• Integrated whole transcriptome profiling revealed a convoluted circular RNA-based competing endogenous RNAs regulatory network in colorectal cancer

  2024cites this paper
• Mitotic Functions and Characters of KIF11 in Cancers

  2024cites this paper
• Identification of Hub genes with prognostic values in colorectal cancer by integrated bioinformatics analysis

  2024cites this paper
• Uncovering Cell Cycle Dysregulations and Associated Mechanisms in Cancer and Neurodegenerative Disorders: A Glimpse of Hope for Repurposed Drugs

  2024cites this paper
• Glucosylceramide Synthase Inhibition in Combination with Aripiprazole Sensitizes Hepatocellular Cancer Cells to Sorafenib and Doxorubicin

  2024cites this paper
• Cellular and Transcriptional Response of Human Astrocytes to Hybrid Protein Materials.

  2024cites this paper
• Coordination of cell cycle and morphogenesis during organ formation

  2024cites this paper
• The Antitumour Mechanisms of Carotenoids: A Comprehensive Review

  2024cites this paper
• Binucleated cell formation and oncogene expression after particulate matter exposure is preceded by microtubule disruption, dysregulated cell cycle, prolonged mitosis, and septin binding

  2024cites this paper
• Endometrial cyclin A2 deficiency is associated with human female infertility and is recapitulated in a conditional knockout mouse model

  2023cites this paper
• Evaluating the mouse neural precursor line, SN4741, as a suitable proxy for midbrain dopaminergic neurons

  2023cites this paper
• Drifting in the deep: Metatranscriptomics and metabarcoding reveal sustained metabolic activity and community composition in hydrothermal vent plume microbial communities

  2023cites this paper
• Low-dose graphene oxide promotes tumor cells proliferation by activating PI3K-AKT-mTOR signaling via cellular membrane protein integrin αV.

  2023cites this paper
• Angelicin inhibits cell growth and promotes apoptosis in oral squamous cell carcinoma by negatively regulating DUSP6/cMYC signaling pathway.

  2023cites this paper
• Cellular Functions of High-Temperature Requirement Factor A4 in Placenta

  2023cites this paper
• Cyclin-dependent kinases in cancer: Role, regulation, and therapeutic targeting.

  2023cites this paper
• Evaluating the mouse neural precursor line, SN4741, as a suitable proxy for midbrain dopaminergic neurons

  2023cites this paper
• Evaluating the mouse neural precursor line, SN4741, as a suitable proxy for midbrain dopaminergic neurons

  2023cites this paper
• Prognostic Biomarkers of Cell Proliferation in Colorectal Cancer (CRC): From Immunohistochemistry to Molecular Biology Techniques

  2023cites this paper
• The Regulation of Cyclins and Cyclin-Dependent Kinases in the Development of Gastric Cancer

  2023cites this paper
• Protective impact of nicotinamide mononucleotide (NMN) and platelet-rich fibrin (PRF) on replicative and radiation-induced senescence of human osteoblasts.

  2023cites this paper
• Melatonin and Prostate Cancer: Anti-tumor Roles and Therapeutic Application

  2023cites this paper
• Mutations in CCNB3 affect its location thus causing a multiplicity of phenotypes in human oocytes maturation by aberrant CDK1 activity and APC/C activity at different stages

  2023cites this paper
• Beta HPV Deregulates Double-Strand Break Repair

  2022cites this paper
• Factors Regulating or Regulated by Myogenic Regulatory Factors in Skeletal Muscle Stem Cells

  2022cites this paper
• Heat Shock Procedure Affects Cell Division-Associated Genes in Gynogenetic Manipulation

  2022cites this paper
• HREM, RNAseq and Cell Cycle Analyses Reveal the Role of the G2/M-Regulatory Protein, WEE1, on the Survivability of Chicken Embryos during Diapause

  2022cites this paper
• Telomeric replication stress: the beginning and the end for alternative lengthening of telomeres cancers

  2022cites this paper
• HREM, RNAseq and cell-cycle analyses reveal the role of the G2/M-regulatory protein, Wee1, on the survivability of chicken embryos during diapause

  2022cites this paper
• Application of Regulatory Cell Death in Cancer: Based on Targeted Therapy and Immunotherapy

  2022cites this paper
• Preclinical studies for improving radiosensitivity of non-small cell lung cancer cell lines by combining glutaminase inhibition and senolysis

  2022cites this paper
• Origanum Sipyleum Methanol Extract in Combination with Ponatinib Shows Synergistic anti-Leukemic Activities on Chronic Myeloid Leukemia Cells

  2022cites this paper
• S-Adenosylmethionine affects ERK1/2 and STAT3 pathway in androgen-independent prostate cancer cells

  2022cites this paper
• The phytochemical, corynoline, diminishes Aurora kinase B activity to induce mitotic defect and polyploidy.

  2022cites this paper
• Identification of alternative protein targets of glutamate-ureido-lysine associated with PSMA tracer uptake in prostate cancer cells

  2022cites this paper
• Decoding the Phosphatase Code: Regulation of Cell Proliferation by Calcineurin

  2022cites this paper
• Keep Calm and Carry on with Extra Centrosomes

  2022cites this paper
• PTBP3 regulates proliferation of lung squamous cell carcinoma cells via CDC25A‐mediated cell cycle progression

  2022cites this paper
• Zanthoxylum bungeanum seed oil inhibits RANKL-induced osteoclastogenesis by suppressing ERK/c-JUN/NFATc1 pathway and regulating cell cycle arrest in RAW264.7 cells.

  2022cites this paper
• A truncated form of the p27 CDK inhibitor translated from pre-mRNA causes G2-phase arrest

  2022cites this paper
• Plasminogen activator, urokinase enhances the migration, invasion, and proliferation of colorectal cancer cells by activating the Src/ERK pathway

  2022cites this paper
• Regulation of HTLV-1 transformation

  2022cites this paper
• SALL4 activates PI3K/AKT signaling pathway through targeting PTEN, thus facilitating migration, invasion and proliferation of hepatocellular carcinoma cells

  2022cites this paper
• Role of Intracellular and Extracellular Annexin A1 in MIA PaCa-2 Spheroids Formation and Drug Sensitivity

  2022cites this paper
• A Truncated Form of the p27 Cyclin-Dependent Kinase Inhibitor Translated from Pre-mRNA Causes G2-Phase Arrest

  2022cites this paper
• Identification of the Top 10 Core Genes as Diagnostic and Therapeutic Targets in Hepatocellular Carcinoma (HCC)

  2022cites this paper
• Hepatic transcriptome analysis reveals the metabolic strategies of largemouth bass (Micropterus salmoides) under different dissolved oxygen condition.

  2022cites this paper
• Coevolution of HTLV-1-HBZ, Tax, and proviral load with host IRF-1 and CCNA-2 in HAM/TSP patients.

  2022cites this paper
• Screening anti-tumor constituents from Potamogeton crispus for potential utilisation of constructed wetland plant resources

  2022cites this paper
• miRNA-338-3p inhibits the migration, invasion and proliferation of human lung adenocarcinoma cells by targeting MAP3K2

  2022cites this paper
• Transcriptomic and Functional Evidence for Differential Effects of MCF-7 Breast Cancer Cell-Secretome on Vascular and Lymphatic Endothelial Cell Growth

  2022cites this paper
• Alachlor breaks down intracellular calcium homeostasis and leads to cell cycle arrest through JNK/MAPK and PI3K/AKT signaling mechanisms in bovine mammary gland epithelial cells.

  2022cites this paper
• Identification of potential therapeutic targets associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis

  2022cites this paper
• Advances in Anti-Cancer Activities of Flavonoids in Scutellariae radix: Perspectives on Mechanism

  2022cites this paper
• Identification of potential core genes in esophageal carcinoma using bioinformatics analysis

  2021cites this paper
• Rosmanol induces breast cancer cells apoptosis by regulating PI3K/AKT and STAT3/JAK2 signaling pathways

  2021cites this paper
• The NUCKS1-SKP2-p21/p27 axis controls S phase entry

  2021cites this paper
• Possible relationship between mitochondrial changes and oxidative stress under low dose-rate irradiation

  2021cites this paper
• Dehydrocrenatidine extracted from Picrasma quassioides induces the apoptosis of nasopharyngeal carcinoma cells through the JNK and ERK signaling pathways

  2021cites this paper
• Pharmacological relevance of CDK inhibitors in Alzheimer's disease.

  2021cites this paper
• Microfragmented adipose tissue is associated with improved ex vivo performance linked to HOXB7 and b-FGF expression

  2021cites this paper
• Sirtuins-Mediated System-Level Regulation of Mammalian Tissues at the Interface between Metabolism and Cell Cycle: A Systematic Review

  2021cites this paper
• Cyclin A2/cyclin-dependent kinase 1-dependent phosphorylation of Top2a is required for S phase entry during retinal development in zebrafish.

  2021cites this paper
• Targeting cell-cycle machinery in cancer.

  2021cites this paper
• Transforming early pharmaceutical assessment of genotoxicity: applying statistical learning to a high throughput, multi end point in vitro micronucleus assay

  2021cites this paper
• Chromatin Remodeling During Leukemia Cell Proliferation and Differentiation

  2021cites this paper